AmgenvsLENSAR

AMGN and LNSR stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$438.82

Value $237B

-1.14%
AMGN's page

LNSR

LENSAR, Inc.

$4.64

Value $56M

-4.33%
LNSR's page

Amgen (AMGN) has a market value of $237B and LENSAR (LNSR) $56M. Over the last year, with dividends, AMGN moved +31.1% and LNSR -53.5%. Dividend yield: AMGN 2.27%, LNSR none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$237B

    LNSR$56M

    AMGN is 4,212 times LNSR

  • Revenue, 12 months

    AMGN$38.9B

    LNSR$60M

    AMGN is 648 times LNSR

  • Net income, 12 months

    AMGN$9.4B

    LNSR$34M

    AMGN is 279 times LNSR

  • Operating margin

    AMGN32.4%

    LNSR-3.3%

    35.7 points apart

  • ROIC

    AMGN16.2%

    LNSR–

  • P/E

    AMGN25.2

    LNSR–

  • Dividend yield

    AMGN2.3%

    LNSR0.0%

    2.3 points apart

  • 5-year return

    AMGN+149.2%

    LNSR-34.7%

    183.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+149.2%

LNSR-34.7%

10020020222023202420252026
Returns by period
PeriodAMGNWith dividendsLNSRWith dividends
1 year since November 18, 2025+31.1%Price +27.6%-53.5%Price -53.5%
3 years since November 17, 2023+79.5%+21.5% a yearPrice +65.3%+111.9%+28.4% a yearPrice +111.9%
5 years since November 18, 2021+149.2%+20.0% a yearPrice +115.1%-34.7%-8.2% a yearPrice -34.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenLNSRLENSAR

Valuation

AMGNLNSR
Valuation
Price$438.82$4.64
Market value$237B$56M
Enterprise value (EV)$277B$45M
P/E25.2–
P/E, 5-year median23.0–
P/B16.55.1
EV/EBIT22.0–
Free cash flow yield4.1%–

Results and growth

AMGNLNSR
Results and growth
Revenue, 12 months$38.9B$60M
Net income, 12 months$9.4B$34M
Free cash flow, 12 months$9.6B-$4.8M
Earnings per share, 12 months$17.25-$0.40
Revenue growth, year on year10.0%9.2%
Revenue growth a year, past+7.6%over 5 years+17.2%over 5 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNLNSR
Margins and returns on capital
Gross margin70.9%52.0%
Operating margin32.4%-3.3%
Net margin24.1%56.1%
ROIC16.2%–
ROE87.8%–

Balance sheet

AMGNLNSR
Balance sheet
Cash$13.2B$13M
Total debt$54.0B$4.1M
Net debt / EBITDA2.3-6.7
Interest cover4.8×–

Dividends and buybacks

AMGNLNSR
Dividends and buybacks
Dividend yield2.3%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield––
Shareholder yield2.3%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or LNSR

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or LENSAR?

By market value, Amgen ($237B) is about 4,211.8 times LENSAR ($56M), at today's prices.

How did AMGN and LNSR stock do over the last 5 years?

Since November 18, 2021, AMGN's price moved +115.1% and LNSR's -34.7%. With dividends: AMGN +149.2% (+20.0% a year), LNSR -34.7% (-8.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or LNSR?

The dividend yield at today's price is 2.27% for Amgen and none for LENSAR. Over the last twelve months they paid $9.94 and – per share.

Which has the higher profit margins, Amgen or LENSAR?

Over the last twelve months, the net margin was 24.1% for Amgen and 56.1% for LENSAR, and the operating margin 32.4% and -3.3%. Revenue was $38.9B and $60M.

Which is the better investment, Amgen or LENSAR?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.